Jordan Nel

Jordan Nel, ex-Hummingbird/Nomads, refuses to defend venture as an asset class: “I’m not sure that venture beta justifies the illiquidity premium.” His case is strictly bottom-up — “for every outlier company, there are at least three outlier funds”: every Coinbase has a Ribbit, a USV, and a dozen funds that return multiples off one name. Even in 2021 there were pockets of arbitrage (“if you were fishing in Indian life sciences, probably you’d be the only one”), and the LP’s job is finding those pockets, not timing beta.

Emerging managers shouldn’t try to beat Andreessen or Sequoia — they should see companies first and “act as signals to the bigger funds such that they will eventually follow on from you.” Big-fund GPs on 20-person teams aren’t incentivized to fish for a $5M post-money-cap founder in the backwaters; they need to deploy $30–100M tickets to drive carry. It’s not either/or: big funds run fund-of-funds programs that seed emerging managers and use them as deal flow.

Nel rejects “contrarian” for “pre-consensus” — the art is making founders “legible to capital” and sequencing the cap table. Bridget Mendler (Disney child star turned PhD, founder of Northwood Space) could have raised from megafunds but deliberately built her pre-seed with signal angels; a founder from Abuja, Nigeria couldn’t get a term sheet for six months until one risk-on pre-seed GP unlocked the San Francisco hard-tech ecosystem. On a founder with direct access to top funds, Nel says he would do it for “Sam Bradberry Taylor,” but adds, “I’m not Bret Taylor,” and most founders can’t.

After four years and meeting 5,000-plus GPs, Nel gave up on a precise GP archetype; the key lenses are “how do they make decisions and who do they hang around?” Indexing on hyper-articulate theses was “a mistake” — sometimes “this is the best founder I’ve met this year” is a back-up-the-truck signal, and the killer calibration question is “Okay, well, who else did you meet this year?” Compound’s Michael is the case study: the theses are visible, but the real edge is “a very, very good nose for who to listen to.”

Edge is cycle- and sector-dependent: in hot Bay Area frontier AI “GPs who win will win,” and if you can’t outbid Sequoia, Conviction, and Benchmark, “you probably shouldn’t play.” In colder sectors, picking wins — which is why institutional LPs were interested in Dimension, the Lux spinout focused on tech bio, as “in some sense… the only game in town.” Forward-looking opportunities include Indian life sciences, Brazil pre-seed (“so few VCs actually writing pre-seed checks”), and capital-starved China — as long as you keep the bar at “global maximum” with San Francisco benchmarks.

Concentration is “downstream of convexity,” not a rule — 40 checks at $2M post are “basically free call options,” but almost nobody besides Silicon Valley Angel has the network to do it without adverse selection. Price discipline swung from lax to overtight before settling on mentality over absolutes: what matters is getting “the best terms at the table,” because “the returns follow the mentality of the GP.” First-fund managers are backable only with a prior angel record: “if you’ve never written a check before, I have no data points to move on.”

The process lesson is constant WhatsApp debate rather than a scheduled IC. Nel’s formative scar tissue is a South African airline he bought going into COVID as deep value, only for the government counterparty not to pay and the business to go bankrupt: “I think probably there is no price.” The venture translation is emotional, not tactical — “I just don’t want to lose the money.”

🔗 Original source & video: Identifying Generational Managers with Jordan Nel